 |
Also known as: Jakafi
The following information is NOT intended to endorse drugs or recommend therapy. While these reviews might be helpful, they are not a substitute for the expertise, skill, knowledge and judgement of healthcare practitioners in patient care.
Learn more about Ruxolitinib.
No reviews have yet been submitted. Be the first to review this drug.
Availability Prescription only
Pregnancy Category Risk cannot be ruled out
Results from the COMFORT-I and COMFORT-II Phase III trials show Jakafi significantly reduced spleen volume and debilitating symptoms associated...
Two new studies confirm that the new drug ruxolitinib can help people with the rare bone marrow disorder called myelofibrosis. While the drug, marketed in the...
- Oral Presentations at 53rd ASH Annual Meeting and Exposition - SINGAPORE, Dec. 12, 2011 /PRNewswire/ -- S*BIO Pte Ltd today announced that results from a...
Drugs.com provides accurate and independent information on more than 24,000 prescription drugs, over-the-counter medicines & natural products. This material is provided for educational purposes only and is not to be used for medical advice, diagnosis or treatment.
Data sources include Micromedex™ (updated Apr 16th, 2012), Cerner Multum™ (updated May 18th, 2012), Wolters Kluwer™ (updated Apr 29th, 2012) and others.
To view content sources and attributions, refer to our editorial policy.
Copyright © 2000-2012 Drugs.com. All rights reserved.
We comply with the HONcode standard for trustworthy health information.
Verify here
